Xbrane Biopharma AB (publ) - Demonstração de Resultados (TTM)

Xbrane Biopharma AB (publ)
Demonstração de Resultados (TTM)

A Demonstração de Resultados de Xbrane Biopharma AB (publ) mostra mudanças na receita e despesas ao longo de um período de tempo. Os dados da Demonstração de Resultados incluem Vendas e Receita, Lucro Bruto, Pesquisa e Desenvolvimento (P&D), Despesas de Vendas, Gerais e Administrativas (SG&A), Renda Operacional, Despesa com Imposto de Renda, Despesa com Juros, Renda Não Operacional, Lucro por Ação (EPS) e Ações em Circulação.

Todos os números são vezes 1,000,000 exceto unidades por ação.

2021
06-30
2021
09-30
2021
12-31
2022
03-31
2022
06-30
2022
09-30
2022
12-31
2023
03-31
2023
06-30
2023
09-30
2023
12-31
2024
03-31
2024
06-30
2024
09-30
2024
12-31
2025
03-31
2025
06-30
2025
09-30
2025
12-31
2026
03-31
Receita 5 8 11 15 32 43 58 112 144 189 239 191 192 149 148 227 266 260 152 76
Mudar (%) 50.00 40.26 44.70 105.36 36.31 32.82 94.58 28.76 31.03 26.21 -20.01 0.48 -22.25 -0.73 53.46 16.94 -2.28 -41.33 -49.82
% da receita 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00 100.00
Custo das vendas 47 86 141 203 162 109 76 18 54 67 60 63 33
Mudar (%) 84.50 63.69 44.54 -20.57 -32.66 -29.95 -76.08 195.03 24.90 -10.51 4.51 -47.42
% da receita 41.55 59.54 74.38 85.18 84.58 56.68 51.07 12.31 23.66 25.27 23.14 41.23 43.19
Lucro Operacional Bruto 5 8 11 15 32 43 58 66 58 48 35 29 83 73 130 174 199 200 90 43
Mudar (%) 50.00 40.26 44.70 105.36 36.31 32.82 13.74 -10.86 -17.03 -26.98 -16.77 182.20 -12.18 77.91 33.59 14.47 0.50 -55.14 -51.50
% da receita 100.00 100.00 100.00 100.00 100.00 100.00 100.00 58.45 40.46 25.62 14.82 15.42 43.32 48.93 87.69 76.34 74.73 76.86 58.77 56.81
Vendas, Gerais e Administrativas 26 32 31 31 29 27 32 36 41 43 40 39 37 39 41 41 49 47 44 40
Mudar (%) 19.91 -0.53 -0.22 -8.04 -7.67 18.58 12.91 14.66 4.11 -5.83 -2.04 -4.55 4.27 4.55 -0.47 19.91 -3.87 -6.40 -7.79
% da receita 517.11 413.37 293.16 202.15 90.52 61.31 54.74 31.76 28.28 22.47 16.77 20.53 19.51 26.16 27.55 17.87 18.32 18.03 28.76 52.86
P&D 200 189 161 151 154 169 200 222 256 286 306 324 296 222 162 109 227 229 118 105
Mudar (%) -5.31 -15.14 -5.86 2.00 9.57 18.14 11.01 15.53 11.84 6.79 5.95 -8.62 -24.91 -27.12 -32.90 108.38 0.90 -48.44 -10.92
% da receita 3,927.29 2,479.07 1,499.85 975.77 484.63 389.57 346.50 197.68 177.36 151.39 128.09 169.65 154.28 149.01 109.40 47.84 85.24 88.02 77.36 137.33
OpEx 227 225 187 173 166 174 210 285 369 459 535 510 430 327 230 209 367 363 172 133
Mudar (%) -0.96 -16.67 -7.46 -3.89 4.43 20.97 35.50 29.46 24.44 16.66 -4.80 -15.70 -23.91 -29.53 -9.32 75.68 -1.16 -52.51 -22.61
% da receita 4,455.21 2,941.69 1,747.74 1,117.74 523.08 400.72 364.94 254.13 255.51 242.67 224.29 266.94 223.96 219.19 155.60 91.94 138.12 139.71 113.08 174.40
Lucro operacional -222 -217 -176 -158 -135 -130 -153 -173 -224 -270 -297 -319 -238 -178 -82 18 -101 -103 -20 -57
Mudar (%) -2.13 -18.67 -10.62 -14.63 -3.11 17.02 13.20 29.91 20.21 9.96 7.44 -25.39 -25.24 -53.69 -122.24 -653.24 1.77 -80.67 185.41
% da receita -4,355.21 -2,841.69 -1,647.74 -1,017.74 -423.08 -300.72 -264.94 -154.13 -155.51 -142.67 -124.29 -166.94 -123.96 -119.19 -55.60 8.06 -38.12 -39.71 -13.08 -74.40
Despesa com juros -1 -2 -3 -4 -3 -3 -3 -2 -4 -1 -19 -29 -33 -46 -31 -28 -31 -24 -12 -6
Mudar (%) 42.78 33.20 33.46 -2.67 -18.60 -7.32 -5.57 52.56 -84.49 3,106.41 57.03 13.16 39.66 -33.31 -8.90 10.02 -21.10 -50.28 -51.72
% da receita -27.23 -25.92 -24.61 -22.70 -10.76 -6.42 -4.48 -2.18 -2.58 -0.31 -7.75 -15.21 -17.13 -30.77 -20.67 -12.27 -11.55 -9.32 -7.90 -7.60
Resultado líquido -231 -219 -188 -173 -148 -144 -173 -195 -252 -291 -388 -427 -407 -371 -266 -161 79 101 127 106
Mudar (%) -5.31 -13.97 -8.04 -14.66 -2.43 19.59 12.91 29.38 15.61 33.22 10.05 -4.80 -8.88 -28.16 -39.66 -149.45 26.54 26.58 -16.69
% da receita -4,542.83 -2,867.82 -1,759.04 -1,117.91 -464.56 -332.54 -299.41 -173.74 -174.58 -154.04 -162.60 -223.70 -211.94 -248.39 -179.76 -70.69 29.89 38.71 83.52 138.65

Source: Capital IQ

How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Other Listings
SE:XBRANE SEK 10,60
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista